Therapeutic potential of PACAP in alcohol toxicity

Neurochem Int. 2019 Mar:124:238-244. doi: 10.1016/j.neuint.2019.01.017. Epub 2019 Jan 22.

Abstract

Alcohol addiction is a worldwide concern as its detrimental effects go far beyond the addicted individual and can affect the entire family as well as the community. Considerable effort is being expended in understanding the neurobiological basis of such addiction in hope of developing effective prevention and/or intervention strategies. In addition, organ damage and neurotoxicological effects of alcohol are intensely investigated. Pharmacological approaches, so far, have only provided partial success in prevention or treatment of alcohol use disorder (AUD) including the neurotoxicological consequences of heavy drinking. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid neuropeptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents including alcohol. In this mini-review, following a brief presentation of alcohol addiction and its neurotoxicity, the potential of PACAP as a therapeutic intervention in toxicological consequences of this devastating disorder is discussed.

Keywords: Alcohol; Neuroprotection; Neurotoxicity; PACAP.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alcoholic Intoxication / drug therapy*
  • Alcoholic Intoxication / metabolism
  • Alcoholic Intoxication / pathology
  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Ethanol / administration & dosage
  • Ethanol / toxicity*
  • Humans
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism
  • Pituitary Adenylate Cyclase-Activating Polypeptide / pharmacology
  • Pituitary Adenylate Cyclase-Activating Polypeptide / therapeutic use*
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use

Substances

  • Neuroprotective Agents
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Vasodilator Agents
  • Ethanol